The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Nicolette A Hodyl1
- Beverly Muhlhausler2
- 1 Robinson Research Institute, The University of Adelaide, and Neonatal Medicine, Women’s and Children's Hospital, Adelaide, SA
- 2 FOODplus Research Centre, The University of Adelaide, Adelaide, SA
This article was written on behalf of, and partially based on discussions held by, members of the Mechanisms and Pathways and Laying the Foundations for Effecting Change panels at the 2014 ANZ DOHaD meeting. Nicolette Hodyl is supported by an MS McLeod Research Fellowship, and Beverly Muhlhausler is supported by a Career Development Fellowship from the National Health and Medical Research Council of Australia (NHMRC).
No relevant disclosures.
Abstract
Research investigating the developmental origins of health and disease (DOHaD) has never had the technology to investigate physiology in such a data-rich capacity and at such a microlevel as it does now.
A symposium at the inaugural meeting of the DOHaD Society of Australia and New Zealand outlined the advantages and challenges of using “-omics” technologies in DOHaD research.
DOHaD studies with -omics approaches to generate large, rich datasets were discussed.
We discuss implications for policy and practice and make recommendations to facilitate successful translation of results of future DOHaD-omics studies.